Andrew is passionate about translating complex science into clear, impactful regulatory and communication documents that ultimately improve patients’ lives. Andrew has contributed to hundreds of projects across a broad spectrum of therapeutic areas and disease states, authoring and leading the delivery of numerous nonclinical and clinical documents throughout every stage of development, from initial concept and pre-IND planning through to full regulatory submissions such as BLAs and MAAs, and into post-approval and post-marketing activities.
Beyond his authoring expertise, Andrew has built and managed high-performing medical writing departments from the ground up. He has driven continuous improvement in quality systems and processes, expanded service offerings, and established structured mentoring and training programmes that have successfully developed aspiring medical writers into independent, confident professionals.
Andrew is an active volunteer with the European Medical Writers Association (EMWA). He runs workshops, is heavily involved in the protocol theme at the forthcoming EMWA Spring Conference in Barcelona, and has served as Web Manager on the Executive Committee.
He combines scientific rigor and regulatory expertise with strong people-leadership skills, commercial awareness, and an unwavering commitment to quality – always keeping the patient at the heart of everything he does.
